The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
again the most obvious example of this is if you look at people at the far end of the Spectrum in terms of metabolic inflexibility we see that in the disease state of type 2 diabetes and in people with type 2 diabetes the increase in the risk for Alzheimer's disease depending on where you look could be anywhere from 40 to even 100%
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.